What Is Acute Myeloid Leukemia? Acute myeloid leukemia (AML) is a type of blood cancer that starts in your bone marrow, which is the soft inner part of your bones where all your blood cells are made.

Acute myeloid leukemia (AML) pushes your bone marrow to make large numbers of abnormal and underdeveloped blood cells called blast cells. These cells crowd out healthy mature red blood cells ...

If you or a loved one were exposed to benzene at work and were diagnosed with cancers such as leukemia, myelodysplasia (MDS), ...

An international clinical trial co-led by Roswell Park Comprehensive Cancer Center has demonstrated that the investigational ...

Sometimes ALL with myeloid markers may be included under AML called AML with lymphoid markers, or mixed lineage leukemias or undifferentiated or biphenotypic acute leukemias (with both lymphocytic ...

Leukemias are named for the type of blood stem cell — lymphoid or myeloid — that is affected and how quickly the disease develops and progresses. Acute leukemias grow rapidly, leading to symptoms, and ...

Kura Oncology and Kyowa Kirin submitted data from the KOMET-001 trial, which the agency will review and decide whether to approve the drug by Nov. 30.

The Food and Drug Administration (FDA) has accepted for Priority Review the New Drug Application (NDA) for ziftomenib as a treatment for adult patients with relapsed or refractory (R/R) acute myeloid ...

September is Leukemia and Lymphoma Awareness ... by the speed of progression (acute or chronic) and the type of blood cell affected (lymphocytic or myeloid). The four main types are: Symptoms ...

However, it has proven difficult to identify such specific antigens in certain cancer types, including acute myeloid leukemia ... with B cell leukemia/lymphoma and multiple myeloma (MM).

That’s pushed many lymphoma physicians away from autologous ... best options for curative therapy for other cancers like acute myeloid leukemia. Allogeneic transplants have also become safer ...

Venetoclax is under clinical development by AbbVie and currently in Phase I for Solid Tumor. According to GlobalData, Phase I drugs for Solid Tumor have a 69% phase transition success rate (PTSR) ...